Literature DB >> 13201635

The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators.

S SHERRY, A TITCHENER, L GOTTESMAN, P WASSERMAN, W TROLL.   

Abstract

Entities:  

Keywords:  ARTERIES, FEMORAL/diseases; ENZYME PRECURSORS; PROTEASES; STREPTODORNASE AND STREPTOKINASE/effects; THROMBOSIS/experimental; TRYPSIN/effects

Mesh：

Substances：

Year:  1954        PMID： 13201635      PMCID： PMC1072549          DOI： 10.1172/JCI103006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

1.  Lysis of thrombi produced by sodium morrhuate in the femoral vein of dogs by human plasmin (fibrinolysin).

Authors:  E E CLIFFTON; C E GROSSI; D CANNAMELA
Journal:  Ann Surg       Date:  1954-01       Impact factor: 12.969

2.  A plasminogen activator in spontaneously active human blood.

Authors:  S MULLERTZ
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

3.  Antifibrinolytic activity in plasma after exposure to cold and after chymotrypsin administration.

Authors:  H JENSEN; D L CHAMOVITZ; E VOLKRINGER; E GRAY; J E GOSNEY; W KOCHOLATY
Journal:  Blood       Date:  1953-04       Impact factor: 22.113

4.  Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma.

Authors:  O D RATNOFF
Journal:  J Clin Invest       Date:  1953-06       Impact factor: 14.808

5.  Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma.

Authors:  E E CLIFFTON; D CANNAMELA
Journal:  J Appl Physiol       Date:  1953-07       Impact factor: 3.531

6.  Partial purification of the trypsin inhibitor from blood plasma.

Authors:  R J PEANASKY; M LASKOWSKI
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

7.  Determination of trypsin inhibitor in blood plasma.

Authors:  S F McCANN; M LASKOWSKI
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

8.  Parenteral administration of trypsin; clinical effect in 538 patients.

Authors:  I INNERFIELD; A ANGRIST; A SCHWARZ
Journal:  J Am Med Assoc       Date:  1953-06-13

9.  Intravenous trypsin; its anticoagulant, fibrinolytic and thrombolytic effects.

Authors:  I INNERFIELD; A SCHWARZ; A ANGRIST
Journal:  J Clin Invest       Date:  1952-12       Impact factor: 14.808

10.  The inactivation of complement and its components by plasmin.

Authors:  L PILLEMER; O D RATNOFF; L BLUM; I H LEPOW
Journal:  J Exp Med       Date:  1953-04       Impact factor: 14.307
View more
  16 in total

1.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

2.  [Lysis of human blood clots in vitro].

Authors:  H ROSOLLECK
Journal:  Klin Wochenschr       Date:  1961-04-15

3.  The mechanism of clot dissolution by plasmin.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

4.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

5.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

6.  Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes.

Authors:  M HUME; W W GLENN; T GRILLO
Journal:  Ann Surg       Date:  1960-04       Impact factor: 12.969

7.  Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization.

Authors:  N BACH; J L AMBRUS; C L SIMPSON; S SHULMAN
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

8.  [Parentreal use of enzymes in medicine].

Authors:  G J MARTIN; J M BEILER
Journal:  Klin Wochenschr       Date:  1958-06-15

9.  [Potential fibrinolytic activity in thromboembolic diseases].

Authors:  S WITTE
Journal:  Klin Wochenschr       Date:  1956-09-01

10.  The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients.

Authors:  W S TILLETT; A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.